Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract
NCT ID: NCT00793091
Last Updated: 2008-11-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
80 participants
INTERVENTIONAL
2008-11-30
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
C-KAD Ophthalmic Solution
4 drops applied daily for 120 days
2
Placebo
4 drops applied daily for 120 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C-KAD Ophthalmic Solution
4 drops applied daily for 120 days
Placebo
4 drops applied daily for 120 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Best-corrected visual acuity of 20/25 to 20/50 in the study eye
Exclusion Criteria
* Presence or History of Glaucoma
* Presence or history of diabetes
* Use of eyedrops
* Use of steroids
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chakshu Research, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chakshu Research, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ira Wong, MD
Role: STUDY_DIRECTOR
Chakshu Research, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pacific Eye Specialists
San Francisco, California, United States
Hunkeler Eye Institute
Overland Park, Kansas, United States
Minnesota Eye Consultants, PA
Minneapolis, Minnesota, United States
Charlotte Eye, Ear, Nose & Throat Associates
Charlotte, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Leslie Lyssenko
Role: primary
Margie Jones
Role: primary
Research Office
Role: primary
Merri Walker
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CK-0109
Identifier Type: -
Identifier Source: org_study_id